Hydra Biosciences
Cambridge, US · Delaware LLC · 2 known investors
Founders & leadership
MM
Magdalene Moran, Ph.D.Executive
BC
Bert Chenard, Ph.D.Executive
RH
Russell HerndonExecutive
TB
Tom BurkeExecutive
Board
VM
Vincent MilesBoard director
JG
PG
Paul GoldenheimBoard director
RC
Robert CarpenterBoard director
SE
Steven E. HallBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$10.5M disclosed across 2 rounds · 2015–2019
▶$1raisedJun 2019 · 97 investors · BiotechnologyRule 506(b)
▶$1raisedJun 2019 · 97 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Vincent MilesDirector
- Steven HallDirector
- Paul GoldenheimDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$10.5MraisedMar 2015 · 7 investors · BiotechnologyRule 506(b)
▶$10.5MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul GoldenheimDirector
- Magdalene Moran, Ph.D.Executive Officer
- Bert Chenard, Ph.D.Executive Officer
- Vincent MilesDirector
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Jean GeorgeDirector
- Tom BurkeExecutive Officer
- Steven E. HallDirector
- Offering amount
- $17.7M
- Amount sold
- $10.5M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Hydra Biosciences's investors?
- Hydra Biosciences's investors include Lightstone Ventures, New Enterprise Associates (NEA).
- How much funding has Hydra Biosciences raised?
- Hydra Biosciences has disclosed $10.5M raised across 2 rounds.
- Where is Hydra Biosciences headquartered?
- Hydra Biosciences is headquartered in Cambridge, US.